Medicare Enrolled

Dr. Xiaojun Yan, MD

Pulmonary Disease · Brooklyn, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3131 KINGS HWY, Brooklyn, NY 11234
7182523590
In practice since 2005 (20 years)
NPI: 1033110788 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yan

Dr. Xiaojun Yan is a pulmonary disease specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Yan performed 6,234 Medicare services across 2,630 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yan received a total of $268,842 from 37 pharmaceutical and/or device companies across 997 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 4% volume in NY $268,842 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,234
Medicare services
Top 4% in NY for pulmonary disease
2,630
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~312 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
1,696 $70 $126
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
1,626 $25 $43
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,479 $80 $140
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
184 $100 $173
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
153 $35 $64
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
152 $106 $199
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
147 $53 $94
Spirometry test
A test that measures the amount of air you can exhale and how fast you can blow it out. The provider evaluates the results to check lung function.
145 $21 $36
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
145 $51 $85
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
117 $116 $197
Smoking cessation counseling, more than 10 minutes
Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes.
94 $31 $47
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
81 $154 $271
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
52 $16 $28
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
52 $36 $94
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
44 $72 $100
Smoking cessation counseling, 4-10 minutes
A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation.
32 $16 $23
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
24 $30 $50
Inhalation treatment for airway obstruction or sputum production
A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production.
11 $9 $15
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$268,842
Total received (2018-2024)
Avg $38,406/year across 7 years
Top 2% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
997
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$251,642 (93.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,891 (3.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,309 (2.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$32,050
2023
$42,948
2022
$53,971
2021
$45,009
2020
$26,387
2019
$33,161
2018
$35,316

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$26,361
GlaxoSmithKline, LLC.
$4,351
Boehringer Ingelheim Pharmaceuticals, Inc.
$261
Insmed, Inc.
$224
Regeneron Healthcare Solutions, Inc.
$187
GENZYME CORPORATION
$168
Philips North America LLC
$164
Actelion Pharmaceuticals US, Inc.
$138
Mylan Specialty L.P.
$50
Amgen Inc.
$44
ANI Pharmaceuticals, Inc.
$31
INOGEN, INC.
$30
Baxter Healthcare
$24
PFIZER INC.
$17
Top 3 companies account for 96.6% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$110,858
Boehringer Ingelheim Pharmaceuticals, Inc.
$73,666
AstraZeneca Pharmaceuticals LP
$50,182
Sunovion Pharmaceuticals Inc.
$13,195
Insmed, Inc.
$12,426
Teva Pharmaceuticals USA, Inc.
$1,860
Genentech USA, Inc.
$1,028
GENZYME CORPORATION
$830
Regeneron Healthcare Solutions, Inc.
$618
Mylan Specialty L.P.
$561
Regeneron Pharmaceuticals, Inc.
$494
Philips Electronics North America Corporation
$493
Actelion Pharmaceuticals US, Inc.
$392
Grifols USA, LLC
$333
Gilead Sciences, Inc.
$250
Inogen, Inc.
$226
Mallinckrodt Hospital Products Inc.
$178
Philips North America LLC
$164
Advanced Respiratory, Inc
$159
ADVANCED RESPIRATORY, INC
$149
Baxter Healthcare
$121
ANI Pharmaceuticals, Inc.
$99
Paratek Pharmaceuticals, Inc.
$88
Novartis Pharmaceuticals Corporation
$79
Amgen Inc.
$68
PFIZER INC.
$52
Circassia Pharmaceuticals Inc
$48
INOGEN, INC.
$30
Circassia Inc.
$28
Electromed, Inc.
$26
Optinose US, Inc.
$23
SANOFI-AVENTIS U.S. LLC
$22
OptiNose US, Inc.
$22
Horizon Therapeutics plc
$18
E.R. Squibb & Sons, L.L.C.
$18
United Therapeutics Corporation
$18
Hikma Pharmaceuticals USA
$18
Top 3 companies account for 87.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · CINQAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · Esbriet · FARXIGA · FASENRA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · InogenOne · LONHALA MAGNAIR · Life 2000 Ventilation System · NIOX · NUCALA · NUZYRA · OFEV · OPSUMIT · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · QVAR · RAYOS · Respiratoriy Care Undiv · Ryaltris · SEEBRI · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · Trilogy 100 · UTIBRON · UTIBRON NEOHALER · Utibron · Vemlidy · Wellcentive Undiv · XOLAIR · Xhance · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pulmonary disease in NY.

Looking for a pulmonary disease specialist in Brooklyn?
Compare pulmonary diseases in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
603
Per 100K population
22.8
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yan is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NY), with speaking/promotional industry engagement in the top 2% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yan experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Yan performed 1,696 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yan receive payments from pharmaceutical companies?
Yes. Dr. Yan received a total of $268,842 from 37 companies across 997 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yan's costs compare to other pulmonary diseases in Brooklyn?
Dr. Yan's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →